Abstract:Polycyclic aromatic hydrocarbons (PAH) such as benzo[a]pyrene (B[a]P) are among the most abundant environmental pollutants, resulting in continuous exposure of human skin and its microbiota. However, effects of the latter on B[a]P toxicity, absorption, metabolism, and distribution in humans remain unclear. Here, we demonstrate that the skin microbiota does metabolize B[a]P on and in human skin in situ, using a recently developed commensal skin model. In this model, microbial metabolism leads to high concentrations of known microbial B[a]P metabolites on the surface as well as in the epidermal layers. In contrast to what was observed for uncolonized skin, B[a]P and its metabolites were subject to altered rates of skin penetration and diffusion, resulting in up to 58% reduction of metabolites recovered from basal culture medium. The results indicate the reason for this altered behavior to be a microbially induced strengthening of the epidermal barrier. Concomitantly, colonized models showed decreased formation and penetration of the ultimate carcinogen B[a]P-7,8-dihydrodiol-9,10-epoxide (BPDE), leading, in consequence, to fewer BPDE-DNA adducts being formed. Befittingly, transcript and expression levels of key proteins for repairing environmentally induced DNA damage such as xeroderma pigmentosum complementation group C (XPC) were also found to be reduced in the commensal models, as was expression of B[a]P-associated cytochrome P450-dependent monooxygenases (CYPs). The results show that the microbiome can have significant effects on the toxicology of external chemical impacts. The respective effects rely on a complex interplay between microbial and host metabolism and microbe-host interactions, all of which cannot be adequately assessed using single-system studies. IMPORTANCE Exposure to xenobiotics has repeatedly been associated with adverse health effects. While the majority of reported cases relate to direct substance effects, there is increasing evidence that microbiome-dependent metabolism of xenobiotic substances likewise has direct adverse effects on the host. This can be due to microbial biotransformation of compounds, interaction between the microbiota and the host's endogenous detoxification enzymes, or altered xenobiotic bioavailability. However, there are hardly any studies addressing the complex interplay of such interactions in situ and less so in human test systems. Using a recently developed microbially competent three-dimensional (3D) skin model, we show here for the first time how commensal influence on skin physiology and gene transcription paradoxically modulates PAH toxicity.

Differential effects of benzo[a]pyrene exposure on glutathione and purine metabolism in keratinocytes: Dose‐dependent and UV co‐exposure effects

Zinc finger proteins and other transcription regulators as response proteins in benzo[a]pyrene exposed cells.

Cumulative Metabolic Effects of Low-Dose Benzo(a)pyrene Exposure on Human Cells.

Meta-analysis identifies key genes and pathways implicated in Benzo[a]pyrene exposure response

Wavelength dependent responses of primary human keratinocytes to combined treatment with benzo[a]pyrene and UV light

BPDE-DNA adduct formation and alterations of mRNA, protein, and DNA methylation of CYP1A1, GSTP1, and GSTM1 induced by benzo[a]pyrene and the intervention of aspirin in mice

Detoxifying effects of optimal hyperoxia (40% oxygenation) exposure on benzo[a]pyrene-induced toxicity in human keratinocytes

A pilot study exploring time- and dose-dependent DNA damage and chromosomal instability caused by benzo[a]pyrene in two urothelial cell types

Nuclear Proteome Analysis of Benzo(a)pyrene-Treated HeLa Cells.

Impact of Skin Exposure to Benzo[a]pyrene in Rat Model: Insights into Epidermal Cell Function and Draining Lymph Node Cell Response

Uncovering SOD3 and GPX4 as new targets of Benzo[]pyrene-induced hepatotoxicity through Metabolomics and Chemical Proteomics

Benzo[a]pyrene treatment leads to changes in nuclear protein expression and alternative splicing.

Commensal-Related Changes in the Epidermal Barrier Function Lead to Alterations in the Benzo[ a]Pyrene Metabolite Profile and Its Distribution in 3D Skin

Benzo[a]pyrene-induced metabolic shift from glycolysis to pentose phosphate pathway in the human bladder cancer cell line RT4

Benzo(a)pyrene-induced cytotoxicity, cell proliferation, DNA damage, and altered gene expression profiles in HT-29 human colon cancer cells

A realistic human skin model to study benzo[a]pyrene cutaneous absorption in order to determine the most relevant biomarker for carcinogenic exposure

Production of reactive oxygen species and 8-hydroxy-2'deoxyguanosine in KB cells co-exposed to benzo[a]pyrene and UV-A radiation.

Effects of Benzo[A]Pyrene Exposure on Human Hepatocellular Carcinoma Cell Angiogenesis, Metastasis, and Nf-Kappa B Signaling

Dynamic Changes Of Xpa, Xpc, Xpf, Xpg And Ercc1 Protein Expression And Their Correlations With Levels Of Dna Damage In Human Bronchial Epithelia Cells Exposed To Benzo[A]Pyrene

The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice

Metabolically Competent Human Skin Models: Activation and Genotoxicity of Benzo[a]pyrene